Skip to main content

Radiation Dose Management Market To Reach USD 423 Million By 2025 – Increasing Investment In Computed Tomography

 What This Report Will Provide?

The study involved four major activities to estimate the current size of the radiation dose management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth:

[226 Pages Report] The global radiation dose management market size is projected to reach USD 423 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9% during the forecast period.

Major Growth Boosters:

Growth of the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344 

COVID -19 IMPACT ON THE RADIATION DOSE MANAGEMENT MARKET

Several countries across the globe have seen non-urgent diagnostic imaging surgeries being postponed due to the pandemic. These procedures utilize additional resources and increase the risk of complications; depending on the procedure, they also increase the chance of needing equipment, resources, or materials such as hospital beds and PPE.

Key developments:

  • In 2018, Sectra AB launched Sectra Dosetrack.
  • In 2018, Sectra AB launched Gadolinium Tracking in its dose monitoring solution.
  • In 2017, DOSE, Qaelum's dose management solution, expanded its reach in radiology and medical imaging departments in the UK.

The radiation dose management solutions segment is expected to grow at the highest CAGR during the forecast period

Based on product & service, the radiation dose management market is segmented into radiation dose management solutions and radiation dose management services. The radiation dose management solutions segment is projected to witness the highest growth during the forecast period. The increasing adoption of radiation dose management solutions by healthcare providers owing to the growing regulations regarding ionizing radiation across the globe is the major factor supporting the growth of this segment.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=82326344 

Growing concerns over radiation exposure

In the last two decades, radiation exposure to patients has increased significantly. This can be attributed to the growing use of radiological procedures such as CT, fluoroscopy, and interventional imaging procedures, coupled with an increase in the radiation doses used in these procedures. In diagnostic imaging modalities, higher tube currents are used for obese patients to improve image quality. Owing to this, the risk of radiation overexposure for obese patients is high.

Regional Growth Analysis:

Based on the region, the radiation dose management market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the radiation dose management market. The large share of North America can be attributed to factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety.

Comments

Popular posts from this blog

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs. The  global autoinjectors market  is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). In terms of Therapy, the global autoinjectors market can be segmented into: Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia) By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018 On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therap...

Medical Device Reprocessing Market – Statistics and Growth Dynamics To 2022

  Expected Revenue Growth: The  global medical device reprocessing market  is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016. What This Report Will Provide? The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent. Major Growth Boosters: The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat ...

Transplant Diagnostics Market Worth USD 5.5 Billion : Technological Advancements In The Field Of Transplant Diagnostics

  What This Report Will Provide? The study involved four major activities in estimating the current size of the transplant diagnostics market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Expected Revenue Growth: [227 Pages Report] The  transplant diagnostics market  is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. Major Growth Boosters: The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics. Download PDF Brochure:  https://www.marketsandmarkets.com/pd...